Is it possible to define an optimal time for chemotherapy after surgery for ovarian cancer?

This publication has 23 references indexed in Scilit:

• The Danish Civil Registration System
  Scandinavian Journal of Public Health, 2011
• Survival of patients with ovarian cancer in central and northern Denmark, 1998–2009
  Clinical Epidemiology, 2011
• Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
  Annals of Oncology, 2010
• Epithelial ovarian cancer: Does the time interval between primary surgery and postoperative chemotherapy have any prognostic importance?
  Acta Obstetricia et Gynecologica Scandinavica, 2009
• Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
  Journal of Clinical Oncology, 2007
• Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer?
  Gynecologic Oncology, 2007
• Influence of interval between primary surgery and chemotherapy on short-term survival of patients with advanced ovarian, tubal or peritoneal cancer
  Gynecologic Oncology, 2006
• The interval from surgery to chemotherapy in the treatment of advanced epithelial ovarian carcinoma
  European Journal of Surgical Oncology, 2006
• Relationship Between Time Interval From Primary Surgery to the Start of Taxane- Plus Platinum-Based Chemotherapy and Clinical Outcome of Patients With Advanced Epithelial Ovarian Cancer: Results of a Multicenter Retrospective Italian Study
  Journal of Clinical Oncology, 2005
• Long-Term Results and Prognostic Factors in Patients with Epithelial Ovarian Cancer
  Gynecologic Oncology, 2000